<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>28987</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_pmc">28987</infon><infon key="article-id_pmid">11056695</infon><infon key="article-id_publisher-id">cc-1-1-041</infon><infon key="fpage">41</infon><infon key="issue">1</infon><infon key="journal-title">Critical Care</infon><infon key="kwd">medium chain triglycerides parenteral nutrition stability</infon><infon key="lpage">44</infon><infon key="name_0">surname:Desport;given-names:Jean-Claude</infon><infon key="name_1">surname:Hoedt;given-names:Brigitte</infon><infon key="name_2">surname:Pelagatti;given-names:V&#233;ronique</infon><infon key="name_3">surname:Lagarde;given-names:Aline</infon><infon key="name_4">surname:Lorieul;given-names:Fran&#231;oise</infon><infon key="name_5">surname:Chalmel;given-names:Dani&#232;le</infon><infon key="name_6">surname:Sultan;given-names:Fabrice</infon><infon key="name_7">surname:Feiss;given-names:Pierre</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">1997</infon><offset>0</offset><text>Twenty-nine day study of stability for six different parenteral nutrition mixtures</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>83</offset><text>What is the backstory?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>95</offset><text>The objective was to determine the stability of particle size of six parenteral nutrition regimens, which were fitted to different pathologies and used by the University Hospital of Limoges. The mixtures contained glucose (30 or 50%), amino acids (Hyperamine&#174;25), and either long-chain triglycerides (20% Intralipide&#174;) or a combination of medium and long&#8211;chain carbohydrate (20%) M&#233;dialigneMD.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>519</offset><text>What are the results?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>528</offset><text>Despite extensive storage, visual inspections, particle size analysis, and physico-chemical tests did not reveal any significant changes in the lipid emulsions. All the formulae tested were stable for 28 days at room temperature and 4&#176;C plus 24 h.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>798</offset><text>Remarks:</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>811</offset><text>These formulae were found to be dependent on the metabolic and clinical requirements of the patients being treated, as discussed earlier.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>953</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>966</offset><text>A recent article, 'Lifestyle factors and the risk of mortality in older adults', was published in the Lancet on 18 December, 2008. This article was a retrospective analysis of mortality in the British elderly. This paper looked at the relationship between the consumption of different parenteral nutrition mixtures and various aspects of the mortality rate. It was found that:

The highest intake of parenteral nutrition mixtures was associated with a higher risk of death from all causes, and the lowest with all causes mortality.

The highest intake of parenteral nutrition mixtures was associated with a higher risk of death from cardiovascular diseases, and the lowest with cardiovascular diseases and all causes mortality.

The highest intake of parenteral nutrition mixtures was associated with a higher risk of death from</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>2289</offset><text>Material and methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>2310</offset><text>The mixtures were not supplemented by electrolytes, trace elements or vitamins. The packages, made of ethylene vinyl acetate (EVA) (Nutripoches NPP235: Pharmacia SA, France), contained 50 or 30% glucose (Aguettant and Cooper Laboratories, St Quentin, France), amino acids 15.28 g/100 ml (Hyperamine 25&#174;, B Braun M&#233;dical SA, France), and 20% lipids consisting of either medium and long-chain triglycerides (M&#233;dialipide&#174;, B Braun M&#233;dical SA, France) or only long-chain triglycerides (Intralipide&#174;, Pharmaica, France) (Table 1). The Central Pharmacy of the hospital filled the packages under nitrogen pressure in a clean room inside a laminary horizontal flux hood. Glucose was introduced first into each mixture bag, followed by the amino acids and finally the lipids. Two packages (one analytical and one observation bag for each regimen) were forwarded by air freight in a cold box to the stability control laboratory (B Braun M&#233;dical SA, Boulogne, France) within 24 h of production. They were stored in a refrigerator at 4 &#177; 1&#176; C (circulating air) for 28 days, then for 24 h at room temperature. At the end of this period, each mixture was compared with the corresponding mother emulsion, which contained only lipids from the same batch. The stability tests were performed according to the following methods.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>3629</offset><text>Visual observation</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3648</offset><text>The colour and aspect of the mixtures was noted, with each being examined for creaming, oily droplets and the presence or absence of yellow traces. These examinations were performed without shaking the mixtures, and were carried out on the observation bags throughout the entire study. In the analytical bags, they were performed at each stage of analysis before and after the homogenization of the mixtures, which was done by inverting the bags 10 times according to the common conditions of use.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4146</offset><text>Visual microscopic observations</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4178</offset><text>Visual microscopic observations (Leitz-Diaplan microscope) calculated the number of droplets with diameter &gt; 2.5 &#956;m. The dilution of the emulsions was 1:10 in order to obtain a final lipid concentration of 2 g/100 ml. The observations were made in a cell counting chamber (Thoma's grads) at &#215; 500 magnification. A significant increase in particles with diameter &gt; 5 &#956;m indicated destabilisation and the presence of particles with diameter &gt; 10 &#956;m revealed a breakdown of the emulsion [1]. Polaroid microphotography (&#215; 1000 magnification) confirmed the observations.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4749</offset><text>Particle size analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4772</offset><text>Particle size analysis was performed with a Coulter Counter TA II, with a 50 &#956;m aperture. The results were expressed in terms of percentage of fat (% of total lipidic fraction) existing as particles in each different diameter class studied. This calculation took into account the number and mean diameter of particles in each class, the fat concentration of the sample, the analytical volume, and the oil density. Two dilutions were studied:</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5215</offset><text>(1) 1:100,000 (final lipid concentration of 2 &#215; 10-4g/100 ml) for particles with diameters between 0.8 and 5.04 &#956;m. This value was then, in reference to internal laboratory values, correlated with the global granulometric state of the emulsions.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5463</offset><text>(2) 1:1000 (final lipid concentration of 2 &#215; 10-2g/100 ml) for particles with diameter &gt; 1.59&#956;m. The acceptable limit, for this method and this last dilution, was 0.40% of fat in the mixture existing as particles with a diameter &gt; 5 &#956;m.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5703</offset><text>The above tests were performed at D1, D3, D7, D10, D14, D21, D28, D28 + 24 h (D29). pH was tested at every granulometric control stage. Conformity to the formula and osmolality was tested at the beginning and at the end of the study. The chemical analysis performed during the study measured the concentrations of the total nitrogen anhydrous glucose and glycerol, in order to confirm the each mixture conformed to its theoretical formulae (accepted limit &#177; 10%).</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>6168</offset><text>Contents, distinctive composition and suggested indications of the six tested parenteral nutrition mixtures</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center" colspan="6"&gt;Formulae&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td colspan="6"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Composition&lt;/td&gt;&lt;td align="left"&gt;1&lt;/td&gt;&lt;td align="left"&gt;2&lt;/td&gt;&lt;td align="left"&gt;3&lt;/td&gt;&lt;td align="left"&gt;4&lt;/td&gt;&lt;td align="left"&gt;5&lt;/td&gt;&lt;td align="left"&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;50% Glucose (ml)&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;650&lt;/td&gt;&lt;td align="left"&gt;600&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;30% Glucose (ml)&lt;/td&gt;&lt;td align="left"&gt;750&lt;/td&gt;&lt;td align="left"&gt;750&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;20% Intralipide&lt;sup&gt;&#174;&lt;/sup&gt; (ml)&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td/&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;20% M&#233;dialipide&lt;sup&gt;&#174;&lt;/sup&gt; (ml)&lt;/td&gt;&lt;td/&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td/&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;600&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Hyperamine&lt;sup&gt;&#174;&lt;/sup&gt; 25 (ml)&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;500&lt;/td&gt;&lt;td align="left"&gt;750&lt;/td&gt;&lt;td align="left"&gt;750&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total volume (ml)&lt;/td&gt;&lt;td align="left"&gt;1750&lt;/td&gt;&lt;td align="left"&gt;1750&lt;/td&gt;&lt;td align="left"&gt;1500&lt;/td&gt;&lt;td align="left"&gt;1500&lt;/td&gt;&lt;td align="left"&gt;1900&lt;/td&gt;&lt;td align="left"&gt;1950&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Nitrogen (g)&lt;/td&gt;&lt;td align="left"&gt;12.8&lt;/td&gt;&lt;td align="left"&gt;12.8&lt;/td&gt;&lt;td align="left"&gt;12.8&lt;/td&gt;&lt;td align="left"&gt;12.8&lt;/td&gt;&lt;td align="left"&gt;19.2&lt;/td&gt;&lt;td align="left"&gt;19.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Glucido-lipidic ratio (% : %)&lt;/td&gt;&lt;td align="left"&gt;47 : 53&lt;/td&gt;&lt;td align="left"&gt;48 : 52&lt;/td&gt;&lt;td align="left"&gt;50 : 50&lt;/td&gt;&lt;td align="left"&gt;50 : 50&lt;/td&gt;&lt;td align="left"&gt;57 : 43&lt;/td&gt;&lt;td align="left"&gt;50 : 50&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;kcal/Nitrogen ratio&lt;/td&gt;&lt;td align="left"&gt;148&lt;/td&gt;&lt;td align="left"&gt;147&lt;/td&gt;&lt;td align="left"&gt;156&lt;/td&gt;&lt;td align="left"&gt;155&lt;/td&gt;&lt;td align="left"&gt;119&lt;/td&gt;&lt;td align="left"&gt;124&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Glucido-lipidic kcal&lt;/td&gt;&lt;td align="left"&gt;1900&lt;/td&gt;&lt;td align="left"&gt;1884&lt;/td&gt;&lt;td align="left"&gt;2000&lt;/td&gt;&lt;td align="left"&gt;1984&lt;/td&gt;&lt;td align="left"&gt;2284&lt;/td&gt;&lt;td align="left"&gt;2381&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Distinctive composition&lt;/td&gt;&lt;td align="left"&gt;Standard&lt;/td&gt;&lt;td align="left"&gt;Standard with MCT&lt;/td&gt;&lt;td align="left"&gt;Low volume &lt;/td&gt;&lt;td align="left"&gt;Low volume with MCT&lt;/td&gt;&lt;td align="left"&gt;Low lipid, high protein content, with MCT&lt;/td&gt;&lt;td align="left"&gt;High kcal, high protein content with MCT&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Suggested indications&lt;/td&gt;&lt;td align="left"&gt;Standard&lt;/td&gt;&lt;td align="left"&gt;Standard&lt;/td&gt;&lt;td align="left"&gt;Cardiac or renal insufficiency&lt;/td&gt;&lt;td align="left"&gt;Cardiac or renal insufficiency&lt;/td&gt;&lt;td align="left"&gt;Ventilation weaning stress&lt;/td&gt;&lt;td align="left"&gt;High requirements&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>6276</offset><text>	Formulae	 			 	Composition	1	2	3	4	5	6	 	50% Glucose (ml)			500	500	650	600	 	30% Glucose (ml)	750	750					 	20% Intralipide&#174; (ml)	500		500				 	20% M&#233;dialipide&#174; (ml)		500		500	500	600	 	Hyperamine&#174; 25 (ml)	500	500	500	500	750	750	 	Total volume (ml)	1750	1750	1500	1500	1900	1950	 	Nitrogen (g)	12.8	12.8	12.8	12.8	19.2	19.2	 	Glucido-lipidic ratio (% : %)	47 : 53	48 : 52	50 : 50	50 : 50	57 : 43	50 : 50	 	kcal/Nitrogen ratio	148	147	156	155	119	124	 	Glucido-lipidic kcal	1900	1884	2000	1984	2284	2381	 	Distinctive composition	Standard	Standard with MCT	Low volume 	Low volume with MCT	Low lipid, high protein content, with MCT	High kcal, high protein content with MCT	 	Suggested indications	Standard	Standard	Cardiac or renal insufficiency	Cardiac or renal insufficiency	Ventilation weaning stress	High requirements	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>7106</offset><text>MCT=medium chain triglycerides. M&#233;dialipide&#174; is a registered trademark (in Germany, Lipofundin&#174; MCT/LCT; in Denmark, Norway and Sweden, Vasolipid&#174;).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>7259</offset><text>Results and discussion</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7282</offset><text>Addition of ions, pH variation, but also lipid and amino acid composition influence the stability of parenteral nutrition mixtures. The six tested mixtures were not ion-supplemented. The nitrogen content and quality of the triglycerides varied depending on the frequent clinical situation for which the mixture was used. There was no microscopic destabilization from D1 to D29 (no change in the colour or aspect of the mixtures). The mixtures at D29 were microscopically identical to the D1 mother emulsions. Analysis of particle size distribution revealed a difference between Intralipide&#174; and M&#233;dialipide&#174; in particles with diameter &lt; 5 &#956;m without by shift in the distribution curves (Figs 1 and 2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7988</offset><text>For particles with diameter &gt; 5 &#956;m, the values were the same for Intralipide&#174; and M&#233;dialipide&#174; (Fig 3). In all mixtures, no evolution (granulometric destablization or breakdown of the emulsion) was observed over the 29 days, regardless of the formula tested (Figs 1,2,3). All the mixtures conformed to the theoretical compositions, and there was not evolution during storage (Table 2). Osmolality and pH were not significantly different from D1 to D29 (Table 3).</text></passage><passage><infon key="file">cc-1-1-041-1.jpg</infon><infon key="id">F1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8455</offset><text>Particle size analysis with Coulter Counter TA II, 50 &#956; m aperture. The results are expressed as a percentage of the fat (% of total lipidic fraction = TLF). Dilution 1:100,000, particle diameters 0.79 to 5.04 &#956; m. Mother emulsions (ME) containing Intralipide&#174; 20% are at 6.83% TLF; those containing Medialipide&#174; 20% are at 3.39 and 2.66% TLF.</text></passage><passage><infon key="file">cc-1-1-041-2.jpg</infon><infon key="id">F2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8803</offset><text>Particle size analysis with Coulter Counter TA II, 50 mm aperture. The results are expressed as a percentage of the fat (% of TLF). Dilution 1:1000, particle diameters 1.59 to 5.04 mm. Intralipide&#174; 20%, ME = 0.42% TLF; Medialipide&#174; 20%, ME = 0.19 and 0.13% TLF.</text></passage><passage><infon key="file">cc-1-1-041-3.jpg</infon><infon key="id">F3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>9067</offset><text>Particle size analysis with Coulter Counter TA II, 50 &#956; m aperture. The results are expressed as a percentage of the fat (% of TLF). Dilution 1:1000, particle diameters &gt; 5.04 &#956; m. Intralipide&#174; 20%, ME = 0.02% TLF; Medialipide&#174; 20%, ME = 0.02 and 0.06% TLF.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>9329</offset><text>Theoretical and D28 + 1 values of total nitrogen, anhydrous glucose and glycerol. None of the formulae at D28 + 1 exceed theoretical values &#177; 10%</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center" colspan="2"&gt;Total nitrogen (g/l)&lt;/td&gt;&lt;td align="center" colspan="2"&gt;Anhydrous glucose (g/l)&lt;/td&gt;&lt;td align="center" colspan="2"&gt;Glycerol (g/l)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;td colspan="2"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Formulae&lt;/td&gt;&lt;td align="left"&gt;Theoretical&lt;/td&gt;&lt;td align="left"&gt;D28 + 1&lt;/td&gt;&lt;td align="left"&gt;Theoretical&lt;/td&gt;&lt;td align="left"&gt;D28 + 1&lt;/td&gt;&lt;td align="left"&gt;Theoretical&lt;/td&gt;&lt;td align="left"&gt;D28 + 1&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;1&lt;/td&gt;&lt;td align="left"&gt;7.31&lt;/td&gt;&lt;td align="left"&gt;7.49&lt;/td&gt;&lt;td align="left"&gt;128.6&lt;/td&gt;&lt;td align="left"&gt;127.5&lt;/td&gt;&lt;td align="left"&gt;6.43&lt;/td&gt;&lt;td align="left"&gt;6.65&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;2&lt;/td&gt;&lt;td align="left"&gt;7.31&lt;/td&gt;&lt;td align="left"&gt;7.21&lt;/td&gt;&lt;td align="left"&gt;128.6&lt;/td&gt;&lt;td align="left"&gt;127.3&lt;/td&gt;&lt;td align="left"&gt;7.14&lt;/td&gt;&lt;td align="left"&gt;7.48&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;3&lt;/td&gt;&lt;td align="left"&gt;8.53&lt;/td&gt;&lt;td align="left"&gt;8.58&lt;/td&gt;&lt;td align="left"&gt;166.7&lt;/td&gt;&lt;td align="left"&gt;178.6&lt;/td&gt;&lt;td align="left"&gt;7.50&lt;/td&gt;&lt;td align="left"&gt;7.28&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;4&lt;/td&gt;&lt;td align="left"&gt;8.53&lt;/td&gt;&lt;td align="left"&gt;8.49&lt;/td&gt;&lt;td align="left"&gt;166.7&lt;/td&gt;&lt;td align="left"&gt;155.5&lt;/td&gt;&lt;td align="left"&gt;8.33&lt;/td&gt;&lt;td align="left"&gt;8.53&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;5&lt;/td&gt;&lt;td align="left"&gt;10.11&lt;/td&gt;&lt;td align="left"&gt;10.17&lt;/td&gt;&lt;td align="left"&gt;171.05&lt;/td&gt;&lt;td align="left"&gt;164.8&lt;/td&gt;&lt;td align="left"&gt;6.58&lt;/td&gt;&lt;td align="left"&gt;6.60&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;6&lt;/td&gt;&lt;td align="left"&gt;9.85&lt;/td&gt;&lt;td align="left"&gt;9.75&lt;/td&gt;&lt;td align="left"&gt;153.85&lt;/td&gt;&lt;td align="left"&gt;148.8&lt;/td&gt;&lt;td align="left"&gt;7.69&lt;/td&gt;&lt;td align="left"&gt;8.15&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>9476</offset><text>	Total nitrogen (g/l)	Anhydrous glucose (g/l)	Glycerol (g/l)	 					 	Formulae	Theoretical	D28 + 1	Theoretical	D28 + 1	Theoretical	D28 + 1	 	1	7.31	7.49	128.6	127.5	6.43	6.65	 	2	7.31	7.21	128.6	127.3	7.14	7.48	 	3	8.53	8.58	166.7	178.6	7.50	7.28	 	4	8.53	8.49	166.7	155.5	8.33	8.53	 	5	10.11	10.17	171.05	164.8	6.58	6.60	 	6	9.85	9.75	153.85	148.8	7.69	8.15	 	</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>9837</offset><text>pH at D1 and D28 +1 for the six mixtures tested</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center" colspan="6"&gt;Formulae&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td colspan="6"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Day&lt;/td&gt;&lt;td align="left"&gt;1&lt;/td&gt;&lt;td align="left"&gt;2&lt;/td&gt;&lt;td align="left"&gt;3&lt;/td&gt;&lt;td align="left"&gt;4&lt;/td&gt;&lt;td align="left"&gt;5&lt;/td&gt;&lt;td align="left"&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;D1&lt;/td&gt;&lt;td align="left"&gt;6.56&lt;/td&gt;&lt;td align="left"&gt;6.55&lt;/td&gt;&lt;td align="left"&gt;6.62&lt;/td&gt;&lt;td align="left"&gt;6.48&lt;/td&gt;&lt;td align="left"&gt;6.42&lt;/td&gt;&lt;td align="left"&gt;6.47&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;D28 + 1&lt;/td&gt;&lt;td align="left"&gt;6.59&lt;/td&gt;&lt;td align="left"&gt;6.56&lt;/td&gt;&lt;td align="left"&gt;6.59&lt;/td&gt;&lt;td align="left"&gt;6.57&lt;/td&gt;&lt;td align="left"&gt;6.51&lt;/td&gt;&lt;td align="left"&gt;6.58&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>9885</offset><text>	Formulae	 			 	Day	1	2	3	4	5	6	 	D1	6.56	6.55	6.62	6.48	6.42	6.47	 	D28 + 1	6.59	6.56	6.59	6.57	6.51	6.58	 	</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>9995</offset><text>Conclusion</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>10006</offset><text>After a prolonged storage period of 28 days at 4&#176;C and 24 hours at room temperature, all six ternary unsupplemented controlled mixtures were stable enough for normal therapeutic use. The choice of triglyceride mixture used was determined solely by the clinical and metabolic requirements of each regimen, as all other stability tests confirmed their stability.</text></passage><passage><infon key="fpage">623</infon><infon key="lpage">634</infon><infon key="name_0">surname:Driscoll;given-names:DF</infon><infon key="name_1">surname:Bhargava;given-names:HN</infon><infon key="name_2">surname:Li;given-names:L</infon><infon key="name_3">surname:Zaim;given-names:RH</infon><infon key="name_4">surname:Babayan;given-names:VK</infon><infon key="name_5">surname:Bistrian;given-names:BR</infon><infon key="pub-id_pmid">7606577</infon><infon key="section_type">REF</infon><infon key="source"> Am J Health-Syst Pharm</infon><infon key="type">ref</infon><infon key="volume">52</infon><infon key="year">1995</infon><offset>10356</offset><text> Physicochemical stability of total nutrient admixtures.</text></passage><passage><infon key="fpage">436</infon><infon key="lpage">453</infon><infon key="name_0">surname:Fujita;given-names:T</infon><infon key="name_1">surname:Sumaya;given-names:T</infon><infon key="name_2">surname:Yokoyama;given-names:K</infon><infon key="pub-id_pmid">5158957</infon><infon key="section_type">REF</infon><infon key="source">Eur Surg Res</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">1971</infon><offset>10413</offset><text>Fluorocarbon emulsion as a candidate for artificial blood.</text></passage><passage><infon key="fpage">64</infon><infon key="lpage">68</infon><infon key="name_0">surname:Bullock;given-names:L</infon><infon key="name_1">surname:Fitzgerald;given-names:JF</infon><infon key="name_2">surname:Walter;given-names:WV</infon><infon key="section_type">REF</infon><infon key="source">J Parenter Enteral Nutr</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">1992</infon><offset>10472</offset><text>Emulsion stability in total nutrient admixtures containing a pediatric amino acid formulation.</text></passage><passage><infon key="fpage">175</infon><infon key="lpage">189</infon><infon key="name_0">surname:M&#252;ller;given-names:RH</infon><infon key="name_1">surname:Heinemann;given-names:S</infon><infon key="section_type">REF</infon><infon key="source">Int J Pharm</infon><infon key="type">ref</infon><infon key="volume">101</infon><infon key="year">1994</infon><offset>10567</offset><text>Fat emulsions for parenteral nutrition. III: Lipofundin MCT/LCT regimens for total parenteral nutrition (TPN) with low electrolyte load.</text></passage><passage><infon key="fpage">101</infon><infon key="lpage">106</infon><infon key="name_0">surname:Barnett;given-names:MI</infon><infon key="name_1">surname:Cosslett;given-names:AG</infon><infon key="name_2">surname:Duffield;given-names:JR</infon><infon key="name_3">surname:Evans;given-names:DA</infon><infon key="name_4">surname:Hall;given-names:SB</infon><infon key="name_5">surname:Williams;given-names:DR</infon><infon key="pub-id_pmid">2108706</infon><infon key="section_type">REF</infon><infon key="source">Drug Safety</infon><infon key="type">ref</infon><infon key="volume">5 (suppl 1)</infon><infon key="year">1990</infon><offset>10704</offset><text>Parenteral nutrition. Pharmaceutical problems of compatibility and stability.</text></passage><passage><infon key="name_0">surname:Gerbaud;given-names:D</infon><infon key="name_1">surname:Lorieul;given-names:F</infon><infon key="name_2">surname:Veber;given-names:C</infon><infon key="name_3">surname:Bourillet;given-names:F</infon><infon key="section_type">REF</infon><infon key="source">Stabilit&#233; compar&#233;e d&#180;une &#233;mulsion TCM/TCL et de deux &#233;mulsions TCL dans onze m&#233;langes nutritifs Grenoble, France: X&#233;me Symposium de la SFNEP</infon><infon key="type">ref</infon><infon key="year">1990</infon><offset>10782</offset></passage><passage><infon key="fpage">72</infon><infon key="lpage">80</infon><infon key="name_0">surname:Ricard;given-names:C</infon><infon key="name_1">surname:Fortune;given-names:R</infon><infon key="name_2">surname:Florent;given-names:M</infon><infon key="name_3">surname:Bardet;given-names:L</infon><infon key="section_type">REF</infon><infon key="source">J Pharm Clin</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">1996</infon><offset>10783</offset><text>Granulom&#233;trie moyenne et distribution granulom&#233;trique des &#233;mulsions lipidiques injectables, param&#224;tres de stabilit&#233; pour la pr&#233;paration des m&#233;langes destin&#233;s &#224; la nutrition parent&#233;rale totale.</text></passage></document></collection>